Related references
Note: Only part of the references are listed.How to Consider Rare Genetic Variants in Personalized Drug Therapy
Volker M. Lauschke et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
Estimating cost savings of pharmacogenetic testing for depression in real-world clinical settings
Alejandra Maciel et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)
Plharmacogenomic Biomarkers for Improved Drug Therapy- Recent Progress and Future Developments
Volker M. Lauschke et al.
AAPS JOURNAL (2018)
Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
S. M. Han et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Multidisciplinary model to implement pharmacogenomics at the point of care
Pedro J. Caraballo et al.
GENETICS IN MEDICINE (2017)
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response
Mikael Kozyra et al.
GENETICS IN MEDICINE (2017)
Prediction of CYP2D6 phenotype from genotype across world populations
Andrea Gaedigk et al.
GENETICS IN MEDICINE (2017)
Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium
C. H. van der Wouden et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
L. V. Kalman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Interethnic variation of CYP2C19 alleles, 'predicted' phenotypes and 'measured' metabolic phenotypes across world populations
I. Fricke-Galindo et al.
PHARMACOGENOMICS JOURNAL (2016)
Genetic Variation Among 82 Pharmacogenes: The PGRNseq Data From the eMERGE Network
W. S. Bush et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Comparison of genome sequencing and clinical genotyping for pharmacogenes
W. Yang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
Fast and accurate long-range phasing in a UK Biobank cohort
Po-Ru Loh et al.
NATURE GENETICS (2016)
Requirements for comprehensive pharmacogenetic genotyping platforms
Volker M. Lauschke et al.
PHARMACOGENOMICS (2016)
Precision Medicine and Rare Genetic Variants
Volker M. Lauschke et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Preemptive Clinical Pharmacogenetics Implementation: Current Programs in Five US Medical Centers
Henry M. Dunnenberger et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Large multiallelic copy number variations in humans
Robert E. Handsaker et al.
NATURE GENETICS (2015)
Genetic variation in the human cytochrome P450 supergene family
Kohei Fujikura et al.
PHARMACOGENETICS AND GENOMICS (2015)
Analyzing the potential for incorrect haplotype calls with different pharmacogenomic assays in different populations: a simulation based on 1000 Genomes data
Matthias Samwald et al.
PHARMACOGENOMICS (2015)
Linking a Population Biobank with National Health Registries-The Estonian Experience
Liis Leitsalu et al.
JOURNAL OF PERSONALIZED MEDICINE (2015)
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α-Based Regimens
A. J. Muir et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Design and Anticipated Outcomes of the eMERGE-PGx Project: A Multicenter Pilot for Preemptive Pharmacogenomics in Electronic Health Record Systems
L. J. Rasmussen-Torvik et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Incorporation of Pharmacogenomics into Routine Clinical Practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline Development Process
Kelly E. Caudle et al.
CURRENT DRUG METABOLISM (2014)
Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset
Adam S. Gordon et al.
HUMAN MOLECULAR GENETICS (2014)
Personalized pharmacogenomics profiling using whole-genome sequencing
Clint Mizzi et al.
PHARMACOGENOMICS (2014)
Clinical and economic challenges facing pharmacogenomics
J. Cohen et al.
PHARMACOGENOMICS JOURNAL (2013)
Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
J. Winner et al.
TRANSLATIONAL PSYCHIATRY (2013)
An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People
Matthew R. Nelson et al.
SCIENCE (2012)
A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated Individuals
Brian L. Browning et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Extension of a pilot study: Impact from the cytochrome P450 2D6 polymorphism on outcome and costs associated with severe mental illness
WH Chou et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2000)
Share Paper
